Stay updated on Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial
Sign up to get notified when there's something new on the Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial page.

Latest updates to the Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial page
- Check5 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed.SummaryDifference0.0%

- Check12 days agoChange DetectedA bibliographic reference (Dimopoulos et al., 2007 NEJM) was added and then removed in the Publications section.SummaryDifference0.0%

- Check19 days agoChange DetectedTwo bibliographic references were added and two related topic tags were removed from the study page.SummaryDifference0.2%

- Check26 days agoChange DetectedAdded related topics: Multiple Myeloma and MedlinePlus Genetics as minor metadata updates; there is no change to the core trial details or user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check33 days agoChange DetectedThe changes are minor metadata updates: a new Revision: v3.4.2 banner and the removal of older topics/links such as Revision: v3.4.1, Multiple myeloma, related topics, and MedlinePlus Genetics. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check40 days agoChange DetectedA government funding notice was added at the top of the page. Related topics (Multiple Myeloma, MedlinePlus Genetics) were added, and the revision tag was updated from v3.4.0 to v3.4.1.SummaryDifference0.5%

Stay in the know with updates to Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial page.